Search | Page 17 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for January 2016

    ... Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies ... has a Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated ...

    Page last updated 01/07/2016 - 10:57am.

  2. Clinical Trials Report for December 2015

    ... Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies ... has a Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated ...

    Page last updated 11/30/2015 - 10:31am.

  3. Transplantation

     

    Page last updated 01/20/2015 - 4:45pm.

  4. Nurse's Corner Summer 2015: Understanding the Etiology and Epidemiology of Myelodysplastic Syndromes

    ... Syndromes (MDS) are a group of malignant hematopoietic stem cell diseases characterized by bone marrow failure , with resultant ... higher risk, the goal of treatment is to improve survival. Allogeneic hematopoietic stem cell transplant and hypomethyalting ...

    Page last updated 07/27/2015 - 12:04pm.

  5. Clinical Trials Report for July 2015

    ... engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens ... a Conventional 10/10 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant This is a pilot study ...

    Page last updated 06/24/2015 - 1:43pm.

  6. Clinical Trials Report for June 2015

    ... engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens ... a Conventional 10/10 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant This is a pilot study ...

    Page last updated 06/18/2015 - 11:47am.

  7. Transplantation Update

    ... toxicity from the regimens used to prepare patients for stem cell transplants regardless of who the donor is or the source of stem ... add that even patients who are 70 may be doing well with an allogeneic transplant but if they develop problems, like GVHD and they are then ...

    Interview last updated 05/14/2015 - 2:42pm.

  8. Clinical Trials Report for May 2015

    ... engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens ... a Conventional 10/10 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant This is a pilot study ...

    Page last updated 04/28/2015 - 11:38am.

  9. Bone Marrow and Stem Cell Transplantation

    ... thinks you may be a candidate for a bone marrow or stem cell transplant , you should start looking for a donor now. It can take ... option for patients with bone marrow failure diseases. Allogeneic transplants use cells from a healthy donor. The donor's tissue type ...

    Page last updated 09/30/2014 - 11:47am.

  10. Clinical Trials Report for December 2014

    ... in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease Some ... identifier: NCT02269280 Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and ...

    Page last updated 11/25/2014 - 3:33pm.